---
title: "礼来公司暂停了与 Zepbound 合作的肌肉保护药物的糖尿病试验 - 彭博社报道"
description: "9 月 25 日（路透社）- 礼来暂停了与 Zepbound 联合进行的肌肉保护药物糖尿病试验 - 彭博新闻"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/258857485.md"
published_at: "2025-09-25T10:40:35.000Z"
---

# 礼来公司暂停了与 Zepbound 合作的肌肉保护药物的糖尿病试验 - 彭博社报道

> 9 月 25 日（路透社）- 礼来暂停了与 Zepbound 联合进行的肌肉保护药物糖尿病试验 - 彭博新闻

Sept 25 (Reuters) -

-   Eli Lilly halts diabetes trial of muscle-sparing drug with Zepbound - Bloomberg news

### Related Stocks

- [LLY.US - 礼来](https://longbridge.com/zh-CN/quote/LLY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Lilly's Moment: AI-Powered Pipeline Positions Shares to Surge in 2026 | Eli Lilly's stock is surging due to AI deals and a favorable drug pricing agreement. The healthcare sector, particularly | [Link](https://longbridge.com/zh-CN/news/267579204.md) |
| Eli Lilly joins a very exclusive club | Eli Lilly becomes the eleventh company to surpass $1 trillion in market capitalization, marking a milestone for healthca | [Link](https://longbridge.com/zh-CN/news/267672421.md) |
| Hazoor Multi Projects Awarded LoA By NHAI | Hazoor Multi Projects Ltd :AWARDED LOA BY NHAIORDER WORTH 442.4 MILLION RUPEES | [Link](https://longbridge.com/zh-CN/news/276092788.md) |
| Indian salon chain Naturals eyeing 2028 IPO if Reliance stake talks fail, executive says | Indian salon chain Naturals is in talks with Reliance for a potential stake sale, but discussions have stalled over the  | [Link](https://longbridge.com/zh-CN/news/276092509.md) |
| Heineken Launches EUR1 Billion Dual-tranche Notes Placement | Heineken Launches EUR1 Billion Dual-tranche Notes Placement | [Link](https://longbridge.com/zh-CN/news/276093598.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。